Category: Pharmaceuticals & Biologics

  Ionis’ ‘Breakthrough’ Alexander Disease Approval Establishes Pillar of Rare Disease Pipeline Zilganersen’s FDA approval gives families confronting Alexander disease their first disease-modifying treatment—and gives Ionis Pharmaceuticals a defining launchpad for a new generation of rare neurological medicines. For Jenny Pearson, the most frightening thing about her daughter Elise’s diagnosis was not simply the name…

  Eli Lilly’s $2.88 Billion Bet on Autoimmune Medicine Inside the Merida Biosciences acquisition—and Lilly’s strategy to build its next growth engine beyond obesity By Jaano & Seekho Editorial Desk September 2026 A New Chapter Beyond Obesity For much of the pharmaceutical industry, few stories have been as transformative as Eli Lilly’s rise through the…

FDA Approves Priovant’s Lisraya for Rare Autoimmune Skin and Muscle Disease Roivant-backed therapy becomes the first targeted treatment approved for adults with dermatomyositis By PharmaDesk International | JaanoAndSeekho.in August 28, 2026 The U.S. Food and Drug Administration (FDA) has approved brepocitinib, a dual TYK2/JAK1 inhibitor developed by Roivant-backed Priovant Therapeutics, for adults with dermatomyositis (DM)—a…

FDA Greenlights Revolution Medicines’ Pancreatic Cancer Gamechanger By PharmaDesk International | JaanoAndSeekho.in August 28, 2026 FDA approval marks a major milestone for targeted RAS therapy in metastatic pancreatic cancer The U.S. Food and Drug Administration (FDA) has approved Revolution Medicines’ RAS inhibitor daraxonrasib for the treatment of patients with metastatic pancreatic cancer, marking a potentially…

Dabur Collaborates With Accenture to Accelerate AI-Led Reinvention Multi-Year Collaboration Targets Data Modernization, Intelligent Decision-Making and Enterprise-Wide AI Adoption Dabur India Limited, one of India’s leading fast-moving consumer goods (FMCG) companies, is collaborating with Accenture to accelerate artificial intelligence (AI) adoption and build a future-ready digital enterprise. The multi-year collaboration is designed to strengthen Dabur’s…

The Architecture of Life: A Detailed Exploration of DNA Sequence Determination, Maintenance, and Mutation By Dr Sanjay Singh Deoxyribonucleic acid (DNA) serves as the primary genetic material for all known life forms. Its sequence, a unique arrangement of four nucleotide bases—Adenine (A), Thymine (T), Cytosine (C), and Guanine (G)—encodes the instructions for development, functioning, growth, and reproduction. The precision with which this…

Orthogonal Methods for Particle Analysis in Biotherapeutics By Dr. Vikas Malhotra Understanding the Role of Orthogonal Methods in Biopharmaceutical Characterization Comprehensive characterization of biotherapeutics is a critical step in ensuring product quality, stability, and efficacy. Given the inherent complexity of biologics, no single analytical technique can provide a complete understanding of all relevant Critical Quality…

Orthogonal Method in Pharmaceutical Analysis: A Scientific Perspective by Dr. Siddhanta Singh Abstract The orthogonal method in pharmaceutical analysis is an essential approach for ensuring data reliability, analytical accuracy, and regulatory compliance. This paper, authored in reference to the expertise of Dr. Siddhanta Singh, reviews the concept, applications, and advantages of orthogonal analytical techniques. By…

Different Design Approaches in the Wearable Injector Market By Sheetal Khanna, Pharmaceutical Packaging Expert As subcutaneous (SC) biologics increase in volume and complexity, the demand for wearable injectors enabling safe and effective at-home delivery continues to grow. Yet unlike the autoinjector and pen segments, which have largely converged on common standards, wearable injectors remain highly…

What effect does X-ray inspection have on pharma products? Pharma manufacturers continue to have concerns over the effect that X-ray inspection could have on their medicines. Are they right to be concerned? Mike Pipe, Head of Global Sales, Mettler-Toledo Safeline X-ray, emphasises that research shows X-ray inspection does not compromise pharma products X-ray technology is…